ZBTB6 inhibitors are a class of chemical compounds that specifically target the ZBTB6 protein, a member of the ZBTB (zinc finger and BTB) family of transcription factors. Like other proteins in this family, ZBTB6 contains two primary functional domains: the zinc finger domain, which enables the protein to bind to specific DNA sequences, and the BTB (Broad-Complex, Tramtrack, and Bric-à-Brac) domain, which mediates protein-protein interactions. ZBTB6 plays an important role in transcriptional regulation, likely functioning as a transcriptional repressor by binding to promoter regions of target genes and recruiting corepressor complexes. The interaction between ZBTB6 and chromatin-modifying proteins or other transcriptional regulators is key to its function in gene repression. Inhibitors of ZBTB6 work by disrupting its ability to bind to DNA or by interfering with critical protein-protein interactions mediated by the BTB domain, leading to altered transcriptional regulation and gene expression.
The mechanisms of ZBTB6 inhibitors can vary, depending on the chemical nature of the compounds and their specific target within the protein. One common approach involves targeting the zinc finger domains, which are essential for ZBTB6's DNA-binding function. These inhibitors may chelate the zinc ions that stabilize the zinc finger motifs, disrupting the structural integrity necessary for ZBTB6 to interact with DNA. This prevents the protein from regulating the transcription of its target genes. Alternatively, inhibitors may act on the BTB domain, which is responsible for mediating the protein-protein interactions required for the formation of transcriptional repression complexes. By blocking these interactions, ZBTB6 inhibitors can impair the protein's ability to recruit corepressors and other regulatory proteins necessary for gene repression. The study of ZBTB6 inhibitors provides valuable insights into the complex mechanisms of gene regulation and highlights the broader significance of protein-DNA and protein-protein interactions in maintaining transcriptional control and cellular function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates various signaling pathways, including those affecting transcription factors, potentially influencing ZBTB6 expression or activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Acts on multiple targets involved in gene expression regulation, which may include pathways regulating ZBTB6. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can disrupt downstream AKT signaling, potentially affecting ZBTB6 if linked to this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which may affect MAPK/ERK signaling pathways that could intersect with ZBTB6's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can alter stress response and apoptosis pathways, potentially affecting ZBTB6's role in these pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can influence cellular growth and proliferation pathways, potentially affecting ZBTB6's regulatory functions. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor that can cause changes in gene expression, possibly influencing ZBTB6 expression. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor that can suppress MAPK/ERK signaling, potentially altering ZBTB6 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that can impact various cellular signaling pathways, potentially affecting ZBTB6 if it is part of PI3K/AKT signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that can alter inflammatory response signaling, potentially affecting ZBTB6's function if involved in these pathways. | ||||||